BioAtla: First Patients Dosed In Phase 2 Platform Clinical Trial Testing Novel Immunotherapy Combinations In Highly Malignant Ovarian Cancer

Press/Media

Period11 May 2022

Media coverage

1

Media coverage

  • TitleBioAtla: First Patients Dosed In Phase 2 Platform Clinical Trial Testing Novel Immunotherapy Combinations In Highly Malignant Ovarian Cancer
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date11/05/22
    PersonsDmitriy Zamarin
View all 1
View less